The SLC6A5 gene helps certain nerve cells recycle glycine, a chemical messenger that calms signals in the spinal cord and brainstem. This gene plays an important role in keeping muscle activity and startle responses under control. If it does not work properly, nerve signaling can become too excitable, which can lead to hyperekplexia, a condition linked to marked startle reactions, body stiffness, and sometimes breathing pauses in newborns.
What is a gene?
A gene is a stretch of DNA that carries information your cells use to make molecules or direct processes in the body. Some genes hold the instructions for making proteins, the working parts of cells. Others mainly help control when certain processes happen, where they occur, and how strongly they run. Taken together, genes influence how the body develops and functions, and they can shape how you respond to food, stress, or medications. To explore this topic in more depth, you can learn more in the LearnHub.
Overview
SLC6A5Gene function
What if the gene works
The SLC6A5 gene helps certain nerve cells recycle glycine, a chemical messenger that quiets signals. This supports steady control of movement, muscle tone, and the normal startle response.
Risk
What if the gene does not work
Variants in the SLC6A5 gene are linked to hyperekplexia, a startle condition causing stiffness and exaggerated responses to sudden noise or touch, often from birth. Milder to more severe variants can affect when symptoms appear and how strong they are.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently tailored specifically to pathogenic variants in the SLC6A5 gene. The SLC6A5 gene is also being studied as a drug target, because blocking its GlyT2 protein may change pain signaling, but this remains research rather than standard care.
Conditions associated with SLC6A5
Gene function
What if the gene works
The SLC6A5 gene helps certain nerve cells recycle glycine, a chemical messenger that quiets nerve activity. This work is especially important in the spinal cord and brainstem, where smooth reflexes and controlled movement depend on balanced signaling. Understanding what the SLC6A5 gene does in the nervous system shows how your body keeps nerve messages from becoming too intense.
This gene makes a transporter that pulls glycine back into the sending nerve cell after a signal is passed. That helps clear the space between nerve cells and keeps communication tidy.
Recovered glycine can be packed and used again for later messages. This steady recycling helps glycine-releasing nerve cells stay ready for frequent, precise signaling.
By maintaining glycine supply, the SLC6A5 gene supports inhibitory signaling, which means signals that calm nerve activity. This helps circuits involved in reflexes, posture, and movement stay more controlled.
What is a variant?
A genetic variant is a minor change in a gene’s DNA sequence. These changes are common and help shape normal differences between people, such as appearance, metabolism, or the way the body responds to environmental influences. Many variants have no noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant changes how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC6A5 gene can change the glycine transporter’s shape, stability, or delivery to the nerve cell surface, so glycine transport becomes less effective and calming nerve signals weaken. SLC6A5 gene variants that affect glycine transport may cause a partial loss of activity or, if more disruptive, almost no transport at all. This range from milder to more severe variants often matches a spectrum of hyperekplexia, with stronger functional loss more often linked to earlier or more marked symptoms.
How variants are linked to conditions
Pathogenic variants in the SLC6A5 gene cause hyperekplexia, a rare neurologic condition also called startle disease. In this established SLC6A5 gene hyperekplexia link, affected newborns or children may have marked stiffness, an exaggerated startle response, and brief breathing pauses. When a disease-causing SLC6A5 variant is found in the right clinical setting, it can help confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC6A5, risk is mostly determined by whether someone is born with a disease-causing change in this gene, often inherited through a family pattern. There is not enough evidence to say lifestyle changes lower the chance of having the condition, although sudden noise, touch, or stress can trigger more startle episodes in people already living with it.
Inheritance of SLC6A5 variants
For families asking how variants of the SLC6A5 gene are inherited, the best-established pattern is autosomal recessive. This usually means a child inherits one changed copy from each parent, while parents with one changed copy are typically carriers. When both parents carry an SLC6A5 gene variant, each pregnancy has a 25% chance of producing a child with the condition, a 50% chance of producing a carrier child, and a 25% chance of producing a child without the variant. Because SLC6A5 is on a non-sex chromosome, this pattern is the same for boys and girls.
What does my SLC6A5 result mean for my family?
For SLC6A5, family members are most often affected in a recessive pattern. This usually means parents are healthy carriers, brothers and sisters may also be carriers, and in some families a sibling could also have the condition. Children of someone with an SLC6A5-related condition will usually be carriers unless the other parent also carries a changed SLC6A5 copy.
Genetic information
Genetic testing
How you find out about variants
SLC6A5 genetic testing looks for variants in the SLC6A5 gene using a blood sample, saliva, or a cheek swab. A lab reads the DNA code and compares it with the usual sequence to see whether a variant is present. Results can confirm a diagnosis or help clarify whether a variant may run in a family.
When should I consider getting a genetic test?
Testing for changes in the SLC6A5 gene can be worth considering when a baby, child, or adult has an unusually strong startle response, body stiffness from birth, or brief pauses in breathing that suggest hereditary startle disease. It can also help when these problems run in the family.
A genetic result is only one part of your health story
A genetic result can be informative, but what it can tell you varies based on the condition and the specific type of variant involved. How the body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medicine or how likely they are to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences affect how people respond to medications. By studying links between genes and drugs, it helps explain why the same treatment can work differently from one person to another. For many medicines, genes influence either how strong a drug’s effects are or how the body handles it. This information can support treatment decisions that are better informed and more individualized. To explore this subject in more detail, more information is available in the LearnHub.
Drugs influenced by the SLC6A5 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how someone will respond to medicines. Questions about symptoms, side effects, or how treatments may affect you are best discussed with your doctor.
History
Families and communities once noticed patterns that seemed to pass from parent to child in the rare inherited startle condition now called hyperekplexia. In the 1990s, researchers began identifying the genes behind this condition, after earlier work had already linked some families to chromosome 11. Soon after, pathogenic variants in the SLC6A5 gene were reported in people with hyperekplexia, showing that more than one gene could underlie the same striking clinical picture. This broadened the medical view of hereditary startle syndromes and helped refine diagnosis in affected families. Building on this early work, scientists uncovered more about the range of SLC6A5 gene variants and how they relate to milder or more typical forms of the condition. These historical steps shaped today’s understanding of inherited hyperekplexia.